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The problem of the treatment and rehabilitation of patients with cerebral stroke has so 
far been one of the most current and difficult in modern clinical practice. Mental pathology 
not only comes to the forefront, but can also be crucial in restoring the motor and speech 
functions of the sick and their social adaptation, as well as influencing the mortality indicator.  
Depression is a common consequence of stroke. Approximately one-third of survivors after 
stroke experience significant symptoms of depression. Post-stroke depression is associated 
with poor quality of life, high disability and poor rehabilitation, higher healthcare use, 
mortality and suicidal ideation. No consensus has yet been reached on the etiology of post-
stroke depression. Post-stroke depression may have multifactorial etiology including organic 
and reactive components. 
Oxidative stress is involved in the pathogenesis of a variety of disease states and may 
be a common pathogenetic mechanism underlying many mental illnesses because the brain is 
relatively more vulnerable to oxidative damage. In the last few years, oxidative stress has 
been seen as one of the contributing factors in the pathogenesis of depression. Recently, it has 
also been discussed as a contributing factor in many chronic neurodegenerative pathologies, 
as well as acute cerebrovascular disorders such as stroke. 
The aim of the paper is to investigate the role of oxidative stress in the 
etiopathogenesis of depressive and anxiety disorders in patients after stroke in order to 
optimize diagnostic therapeutical and medical-social approaches. 
The following tasks have been placed: 
1. Present the influence of the main socio-demographic characteristics (gender, age, 
education and marital status) and personality anxiety on the development of affective 
disorders of patients after stroke. 
2. Analyze the dependence of the occurrence of post-stroke affective disorders on the 
localization of the hearth of brain damage, the severity of the stroke. 
3. Present the psychopathological characterization and determine the severity of the 
depressive disorder in the acute phase after a stroke. 
4. Investigate the correlation between depressive disorder and generalized anxiety 
disorder in postsynaptic patients. 
5. Determine whether there is a link between the presence of depression and the 
presence of panic disorder in postsynaptic patients. 
6. Investigate the level of reactive oxygen species (ROS) and nitrogen oxide (NO) 
generation in post-stroke patients depending on the presence of depressive disorder and its 
severity. 
7. Determine the level of malondialdehyde (MDA), as a marker of oxidative damage 
to lipids, protein kinase (PC), oxidative damage marker of proteins, and 8-OHdG, a marker of 
oxidative DNA damage, in post-stroke patients depending on the presence of depressive 
disorder and its severity. 
8. Investigate the level of the superoxide dismutase (SOD) and catalase (CAT) 
enzymes, as well as the non-enzymatic antioxidants (ascorbate radicals) in post-stroke 
patients depending on the presence of depressive disorder and its severity. 
The contingent of the study was 93 stroke patients, of which 59 men (39-83 years) and 
34 women (56-87 years), with avarage age 66.8 years. Patients treated at the Neurological 
Clinic to the University Hospital "Prof. Dr. Stoyan Kirkovich" in Stara Zagora for the period 
2015 - 2016, meeting the criteria set out in the protocol, are being informed in advance of the 
objectives, tasks and methods of the study and have provided written consent for 
participation. All selected patients were examined for oxidative stress in the Oxidative stress 
and EPR spectroscopy laboratories. For comparison, a control group of 32 healthy individuals 
(14 men and 18 women) of the same sex and age was established. 
The methodologies used are clinical, questionnaire, statistical and laboratory. The 
clinical methods include collecting complete information from patients, if possible and / or 
from close relatives, and available medical documentation on the underlying disease and 
concomitant illnesses, with emphasis on accompanying psychiatric history, deprivation of 
overall mental status, focusing on the affective sphere, somatic and neurological status and 
application of assessment scales (HAM-D-17, MMSE, NIHSS, STAI, PHQ-9, PHQ-15, 
GAD-7). 
The survey method is an individual survey developed specifically for the purpose of 
the protocol, including socio-demographic indicators. 
The statistical method includes analyzes performed using the Windows 7 statistical 
software package, STATISTICA version 10 (StatSoft, Inc.). 
Laboratory methods include instrumental, biochemical, spectrophotometric, EPR and 
immuno-enzymatic methods. 
The impact of socio-demographic factors and personality anxiety on the presence and 
severity of post-stroke depression were investigated. Of all the patients with depressive 
symptoms we studied, there were 25 (73.5%) women and 35 (59.3%) men. Of the women 
with depression 7 (20.6%) have mild, 7 (20.6%) have moderate, 2 (5.9%) have moderate-to-
severe and 9 (26.5%) have severe depression. Of the men with depression 15 (25.4%) are 
mild, 11 (18.6%) have moderate, 8 (13.6%) are moderate-to-severe and 1 (1.7%) have severe 
depression. In women, it is more pronounced than in men (p <0.01). The incidence of 
generalized anxiety disorder was found in 28 (82.35%) of women and 42 (71.2%) of men. Of 
all women with GAD, 9 (26.5%) are mild, 10 (29.4%) are moderate and 9 (26.5%) are severe. 
Of all men with GAD, 17 (28.8%) are mild, 19 (32.2%) are moderate and 6 (10.2%) are 
severe. In contrast to depression, there was no statistically significant gender difference in 
GAD (p >0.05). 
In the results obtained, there was no correlation between the age of the post-stroke 
patients and the presence of GAD, and we found no effect on the degree of depression in the 
family situation. On the other hand, within the framework of the results obtained, there is a 
statistically significant difference between the degree of GAD in single patients (divorced, 
unmarried, widowed) and family (p <0.05). In families, there is a higher degree of GAD 
compared to unmarried people. 
When comparing Hamilton test results with the situation anxiety test, there is a strong 
dependence, i.e. there is a strong correlation between the degree of depression and the 
presence of personality anxiety (p <0.001). With the increase in situational anxiety, the rate of 
depression increases. There is also a statistically significant relationship between the presence 
of personality anxiety and the degree of depression (p <0.001). As the degree of personality 
anxiety increases, the rate of depression increases. There is a very strong relationship between 
the presence of situational anxiety and the degree of generalized anxiety disorder (p<0.001). 
With the presence of situational anxiety, the degree of GAD is also increasing. We also found 
a strong relationship between the presence of personality anxiety and the degree of GAD 
(p<0.001). In the presence of personality anxiety, the degree of GAD increases.  
 The dependence of the occurrence of post-stroke affective disorders on localization of 
the hearth of brain defeat and the severity of stroke was investigated. Our results show no 
dependence between the location of brain defect in patients with stroke and the severity of 
depressive disorder (p >0.05). Of all patients studied, 73 (78.5%) with mild and 20 (21.5%) 
with moderate to severe stroke. There was no statistically significant relationship between the 
severity of the stroke and the severity of the depressive disorder (p> 0.05). Of the examined 
patients, 70 (75.25%) had GAD (27.95%) with mild, (31.2%) with moderate and (16.1%) 
with severe. Our results do not indicate relationship between the location of the stroke and the 
severity of the GAD (p> 0.05). 
Comorbid depressive disorder in the patients we studied was diagnosed according to 
the ICD-10 criteria for depressive disorder: within one depressive episode (F 32) or a 
recurrent depressive episode (F 33). In (16.6%) of the depressed patients studied, the 
depressive episode was within recurrent depressive disorder and in (83.4%) depressive 
symptoms were newly diagnosed. 
Of all post-stroke patients we studied 64.5% have depressive disorder. The severity of 
the diagnosed depressive states is objectively evaluated by HAM-D-17. Dominant in patients 
with mild depressive episode (36.6%) and moderate depressive episode (30%). Fewer are 
patients with moderate-to-severe depressive episode 10 (16.6%) and severe depressive 
episode - 10 (16.6%). We have not observed psychotic symptoms within the depressive 
disorder.  
The levels of free radicals were examined. Free radicals consist of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS). There was a statistically significant 
increase in ROS values in post-stroke patients with severe depression compared to the control 
group, post-stroke patients without depression and with moderate depression (p <0.05). There 
is also a statistically significant increase in patients with moderate depression compared to the 
control group, post-stroke patients without depression and with mild depression (p <0.05).  
!  
A statistically significant increase in post-stroke depression patients (p <0.05) was 
observed in nitrogen oxide levels contained in reactive nitrogen species (RNS) with regard to 
post-stroke patients without depression. In addition, the increase in nitrogen oxide levels in 
post-stroke patients and the control group (p <0.05) is also statistically significant. 
Statistically significant is also the increase in post-stroke patients without depression 
compared to the control group (p <0.05). The results show statistically significant increase in 
nitrogen oxide (NO) levels in patients with moderate depression compared to the control 
group, post-stroke patients without depression and patients with mild depression (p <0.05). 
There is also  statistically significant increase in patients with severe depression compared to 
the control group and patients with mild depression (p <0.05). 
!  
The marker levels of oxidative damage to lipids, proteins and DNA were investigated. 
MDA (malondialdehyde) is an intermediate compound and a major indicator of the lipid 
peroxidation process. The results in the patients with stroke in our study showed that plasma 
MDA levels were significantly higher than in controls and confirmed those from other 
observations. Statistically significant is the increase in post-stroke patients with depression 
from post-stroke patients without depression (p <0.05) and the control group (p <0.05). 
An increase in MDA values was observed in comorbid patients with severe depression 
compared to the control and follow-up group without depression, with mild and moderate 
depression (p = 0.05). 
!  
Protein carbonyl (PC) is a marker for oxidative damage to proteins. There is a 
statistically significant increase in PC levels in post-stroke patients with depression compared 
to the control group (p <0.05), and post-stroke patients without depression compared to the 
control group (p <0.05). 
In a PC study, a statistically significant increase was seen in patients with severe, 
moderate, mild depressive disorder and post-stroke patients without depression compared to 
the control group (p <0.05). As the severity of depression increases, the carbon content 
increases. 
!  
8-OHdG (8-hydroxy-2-deoxyguanidine) is a marker for oxidative DNA damage. There 
is a statistically significant increase in 8-OHdG marker levels in post-stroke patients with 
depression than post-stroke patients without depression (p <0.05) and the control group 
(p<0.05). Furthermore, the difference was statistically significant and between post-stroke 
patients and the control group (p < 0.05). 
A statistically significant increase was observed in post-stroke patients with severe 
depression compared to the control group (0.81), post-stroke patients without depressive 
disorder and patients with mild depression (p <0.05). Statistically significant is also the 
increase in patients with moderate depression compared to the control group, patients without 
depression and patients with mild depression (p <0.05). As the severity of depression 
increases, levels of the 8-OHdG marker increase. 
!  
The levels of enzyme and non-enzymatic antioxidants have been investigated. The 
results obtained on erythrocyte SOD activity showed a statistically significant decrease in 
post-stroke depressive disorder compared to the control group (p <0.05) as well as in post-
stroke patients without depression (p <0.05). Increased generation of ROS depletes the 
antioxidant enzyme SOD, which is first included in the antioxidant protection system. 
Therefore, superoxide anions form high amounts of hydrogen peroxide (H2O2) catalyzed by 
the catalase enzyme (CAT). 
In the SOD study, a statistically significant decrease was observed in post-stroke 
patients with severe, moderate, mild depression and non-depressed patients (p <0.05). The 
lowest values are observed in patients with moderate depression. 
!  
Our results showed that there was a statistically significant increase in erythrocyte 
lysate catalase activity in post-stroke patients with depression (p <0.05) and post-stroke 
patients without depression (p <0.05) and compared to the control group (p <0.01). In 
addition, elevation was statistically significant in post-stroke patients without depression 
compared to the control group (p <0.05). The high activity of CAT is due to the high levels of 
hydrogen peroxide (H2O2), which is formed by the superoxide anion radical (O2-). The 
enzyme catalase significantly prevents the formation of hydroxyl radicals (OH) which are the 
most toxic radicals to the organism from reactive oxygen species. 
Statistically significant increases in erythrocyte CAT levels in post-stroke patients with 
severe depression compared to the control group (p <0.05), as well as compared to patients 
with mild, moderate and post-stroke patients with no depression (p <0.05) have been 
observed. Also, the elevation of CAT in post-stroke patients without, with mild and moderate 
degrees of depression was statistically significant compared to the control group (p <0.05). 
This is due to the increase in H2O2 levels in the more severe degrees of depressive disorder. 
!  
Ascorbate radicals are non-enzymatic antioxidants that lower levels of oxidative 
stress. In the assay of ascorbate radicals, a statistically significant increase was observed in 
post-stroke patients without depression compared to the control group (p <0.05). Statistically 
significant is the decrease in post-stroke patients with depression compared to post-stroke 
patients without depression (p <0.05).  
 Statistically significant increases were observed in patients without depression and in 
patients with mild depression compared to the control group (p <0.05). On the other hand, as 
the severity of depression increases, the levels of ascorbate radicals decrease. A statistically 
significant decrease compared to the control group, patients without depression and mild 
depressive patients was observed in patients with severe depression (p <0.05). In moderate 
depressive patients, there was a statistically significant decrease compared to patients without 
depression and with mild depression (p <0.05). 
!  
Summarizing the results, it is found that the development of post-stroke depression is 
a common mood disorder affecting about a third of the patients with stroke. In our study, 
depressive disorder was reported in two-thirds of the patients with stroke.  
 When analyzing the impact of sociodemographic factors on triggering post-stroke 
depression, we report that female gender is associated with a statistically significant (p <0.01) 
higher risk of developing more severe post-stroke depression. There is also a trend that 
despite the lack of statistically significant difference in our study, female gender is a risk 
factor for the presence of GAD. We have not found a loneliness impact on post-stroke 
depression, whereas a negative correlation is observed with the GAD. The specific features of 
the person as a high level of personality anxiety are also a high risk factor for post-stroke 
depression. The high degree of personality anxiety also correlates with a high degree of 
generalized anxiety disorder.  
 In the majority of cases, the comorbid depressive disorder in the patients studied is 
mild and moderate. Against the backdrop of low mood (81.6%) and sadness (73.3%), 
increased mental (86.6%) and somatic (78.4%) anxiety, insomnia, predominantly early 
morning wake, the low degree of expressiveness of endogenous depression, the supernatural 
thoughts of inferiority, guilt and hopelessness. Suicidal thoughts shared 1.7% of depressed 
patients, with only one experiencing suicidal experiences in the past. Most patients, 52 
(86.7%), with post-stroke depression, are involved in somatic complaints (weight in the 
extremities, back or head, back pain, head or muscle, loss of energy and easy tiredness) and 
their extraordinarily hypochondriac thoughts (78.3%). Using Factor Analysis, Savina MA 
(2016) outlines the limits of post-stroke depressive syndrome that has a mosaic structure and 
includes the following depressive symptoms: grief (87.3%), anhedonia (55.1%), depressive 
apathy (25.4%), hopelessness (25.4%) and dysphoria (50.8%), as well as the presence of 
vegetative disorders. The syndrome it describes does not fully comply with the criteria of 
international classifications: it often involves dysphoria, as well as asthenopoietic disorders 
such as weakness and tiredness, which add to the organic spectrum disorders. 
Arnaudova M. 2015 discusses concerns about own body health, late-depression with 
frequent "masking" behind somatic symptoms, making it difficult to diagnose and treat these 
conditions in a timely manner. However, there is no doubt that somatic symptoms in the 
elderly may not be associated with depression, which would underestimate actual somatic 
problems. Depressions in the elderly are to a large extent "somaticated", i.e. the somatic 
symptoms prevail over the others. Insofar as the clinical manifestations of the depressive 
disorder of the stroke are predominantly somaticated, with predominance of the anxiety 
disorders (Surname et al., 2005) it is necessary to take attention to the high sensitivity of 
patients, even to a slight increase in body discomfort in post-stroke depression. The socio-
cultural traditions of the Bulgarian people also contribute to the fact that patients more often 
and willingly communicate to the treating physicians somatic complaints, considering the 
emotional discomfort as an unimportant and unreasonable discussion. 
The brain with its high oxygen consumption and lipid-rich environment is considered 
highly susceptible to oxidative stress or redox imbalances. Oxidative stress is an imbalance 
between the biochemical processes generating ROS and the ability of a biological system to 
neutralize them. As a result, ROS are formed faster than cellular defense systems can remove 
them (Gadjeva 2007). It has been shown that depression in somatically healthy patients is 
associated with increased blood cytokine concentrations (Dowlati et al., 2010), increased 
levels of ROS and RNS (Maes et al 2011a, Maes 2011b, Suzuki et al 2001, Dhir et al 2011). 
In addition, significantly lower plasma concentrations of several key antioxidants such as 
vitamin E, zinc and coenzyme Q10, and antioxidant-reduced enzyme activity, as well as 
reduced brain glutathione (GSH) levels, have been reported in a major depressive episode 
(Maes et al., Gawryluk et al., 2011). Free radicals are the result of the oxidative-reductional 
reactions occurring in the body. They are paramagnetic particles, molecules, atoms or ions 
that can accept or deliver electrons and create a chain reaction that can cause significant 
biological damage (Gadjeva 2007a, 2007b, 2007c). The existence of a possible link between 
depression and inflammation of the central nervous system is suggested in several recent 
articles on neuroimmunology of stroke (Vogelgesang et al., 2011, Pachner et al., 2012). 
Mechanisms associated with post-stroke depression may include an imbalance between pro-
inflammatory and anti-inflammatory activity that is responsible for increasing oxidative stress 
and may weaken cognitive sensitivity. Recent studies have shown that oxidative and nitrate 
stress can contribute to the pathogenesis of depression by participating in neurogenesis, 
neuroplasticity, nerve inflammation and monoamine reuptake (Pae et al., 2004, Pae et al., 
2008). The latter trend is that antidepressants have a therapeutic effect by suppressing the 
production of inflammatory cytokines, ROS and RNS, or even increasing antioxidant 
protection (Lee et al., 2013). In our study, a statistically significant increase in ROS values 
was observed in patients with severe depression compared to the control group, patients 
without depression and with moderate depression (p <0.05). 
Brain ischemia unlocks a complex cascade of metabolic events, most of which involve 
the formation of nitrogen and oxygen free radicals. Oxidative stress during stroke has a 
significant impact on irreversible damage to neurons (Safwen et al., 2014, Chen et al., 2014, 
Abd-Elsameea et al., 2014, Lee et al., 2014). As a result of hypoxia, oxygen and glucose are 
depleted in the brain tissue, which are the main products for ATP synthesis. This inhibits the 
activity of the sodium-potassium pump and increases the flow of calcium ions into the cell. 
Increased Ca2+ concentration in the cell results in the activation of Ca2+ dependent enzymes, 
including proteases and nucleases responsible for neuronal degradation processes (Broughton 
et al., 2009). 
Based on the facts above, the present study is designed to investigate the possible 
relationship between the level of typical markers of oxidative and nitrile protein modifications 
(protein-carbonyl groups, CAT) and the degree of post-stroke depression. Oxidation of amino 
acid residues leads to the formation of relatively stable protein-carbonyl groups, which can be 
qualitative and quantitative markers allowing the evaluation of oxidative damage to proteins 
(Dalle-Donne et al 2003a, Dalle-Donne et al., 2003b). In our study, oxidative damage to 
proteins has been documented as an increased concentration of protein-carbonyl groups in 
plasma proteins in patients after ischemic stroke. In addition, there is a significant positive 
correlation between the level of carbonylation and the severity of depression. We showed 
more than double increases in the protein-carbonyl groups in the post-stroke patients 
compared to healthy subjects. Our results are consistent with previous reports (Cichon et al., 
2015). The results show for the first time a significant correlation between the degree of 
oxidation of amino acid residues in plasma proteins and the severity of depression in patients 
after a stroke. 
We reported an increase in NO levels in patients with post-stroke depression, with the 
highest levels in moderate and severe depressive disorders. Although the clinical benefit of 
NO synthase polymorphisms has not yet been determined, Kudlow et al. 2016 highlight the 
possibility of treating a major depressive disorder with pharmacological agents by reducing 
NO levels. Evidence suggests that many current antidepressants, initially thought to primarily 
act on neurotransmitters, can actually be mediated by normalizing NO levels by affecting 
several interconnected pathways (eg, microglial activity) (Liu et al., 2011, Lu et al. 2013, 
Tynan et al. 2012) or phosphodiesterase enzyme activity (Reierson et al., 2011). Perhaps the 
approach complementary to three strands where traditional antidepressants are used in 
combination with pharmacological agents aimed at normalizing NO and inflammatory 
signaling pathways, would be most appropriate.  
 The production of radicals in the brain is due to catecholamine metabolism, such as 
dopamine and norepinephrine, and is increased by the presence of transition metals and 
antioxidant deficiency. Due to the high toxicity of free radicals, the body has developed a 
number of specialized and effective methods for deactivating them. The superoxide dismutase 
enzyme (SOD) catalyzes dissociation of the superoxide radical in hydrogen peroxide (H2O2) 
and oxygen (O2). Hydrogen peroxide is then reduced to water and molecular oxygen by the 
enzymes peroxidase, glutathione and catalase (Venarucci et al., 1999). Catalase is not directly 
involved in the elimination of ROS, but does not allow Fenton's reaction in which hydrogen 
peroxide is converted to highly toxic hydroxyl radicals. In our study, we noticed that the 
catalase activity in erythrocytes of patients with stroke was about five times higher than that 
of a healthy control group, this dependence being almost double higher in patients with severe 
post-stroke depression. The superoxide dismutase enzyme (SOD) is inhibited by ROS in 
depressive patients. There is no significant difference in SOD levels at different degrees of 
depression. Of importance for the decrease of SOD is the presence of depressive disorder 
after a stroke. In our study in depressive post-stroke patients, CAT levels are high, which 
decomposes hydrogen peroxide as a second level of protection against oxidative stress, and 
the potential for dealing with the body's oxidative stress is still high in the early days after the 
stroke. Severe depressive disorder correlates statistically significant with the high CAT levels. 
In post-stroke patients with depressive disorders, non-enzymatic ascorbate radicals are rapidly 
depleted as a biomarker of oxidative stress. We observed that in the severe degrees of 
depression the lowest level of ascorbate radicals compared to the milder degrees of depression 
is therefore the lowest opportunity to compensate for oxidative stress. For this reason, 
complex therapy of depression is a recommended intake of vitamin C. 
From this study we can draw the following conclusions:  
1. The role of socio-demographic factors in the development of affective disorders of patients 
after a stroke is relatively weak. 
1.1. Self-importance is only gender for the development of depression. In lonely 
patients, GAD occurs at a lower level than in family. The remaining socio-demographic 
factors studied (age and education) have no effect on the occurrence of affective disorders. 
1.2. The specific features of the personality as a high level of personality anxiety are 
also a high risk factor for post-stroke depression and generalized anxiety disorder. 
2. There was no statistically significant dependence of the occurrence of post-stroke 
affective disorders on localization of the hearth of brain damage and the severity of the stroke 
in post-stroke patients. There is no statistically significant correlation between the severity of 
depression and localization and the severity of the stroke. 
3. Depressive disorder in the acute phase after stroke was found in approximately 2/3 
(64.5%) of patients with stroke, prevail those with mild and moderate-to-severe depressive 
disorders with mood swings, sadness, increased mental and somatic anxiety , insomnia, 
somatic complaints, with extravagant hypochondriac thoughts. 
4. Generalized anxiety disorder in post-stroke patients was found in 70 (75.25%). 
There is a statistically significant positive correlation between depressive disorders and 
generalized anxiety disorders - increasing of severity of depressive disorder increases the 
severity of generalized anxiety disorder as well. 
5. There is no statistically significant correlation between the presence of depression 
and the presence of panic disorder in post-stroke patients. 
6. The levels of reactive oxygen species (ROS) and nitric oxide (NO) generation in 
post-stroke patients are dependent on the presence of depressive disorder and its severity. 
6.1. In post-stroke patients with depression, there is increased generation of reactive 
oxygen species (ROS). The highest are the ROS levels in the severe compared to the lower 
degrees of depression. 
6.2. Nitrogen Oxide (NO) is significantly increased in patients with post-stroke 
depression. Severe degrees of depression correlate statistically significantly with higher levels 
of nitric oxide. 
7. Malondialdehyde (MDA), a product of lipid peroxidation during the oxidative 
stress, protein-carbonyl (PC), as a marker for oxidative damage to proteins and the level of 8-
OHdG, a marker of oxidative DNA damage, are increased in depressive post-stroke patients. 
The worst degrees of depression correlate statistically significant with the highest levels of all 
three markers. 
8. The superoxide dismutase enzyme (SOD) decreases in the presence of depressive 
disorder after a stroke, but there is no significant difference in SOD levels at different degrees 
of depression. In depressive post-stroke patients, catalase enzyme (CAT) levels are high and 
severe depressive disorder correlates statistically significant with higher CAT levels. The 
smallest opportunity to deal with oxidative stress is found in severe degrees of depression due 
to low levels of ascorbate radicals. Because of these results, antioxidants such as vitamin C, 
coenzyme Q, omega 3 and others are also appropriate for the complex treatment of depression 
with antidepressants.
